"GERMAP – Antibiotic Resistance and Consumption" is a report whose specificity consists in the direct compilation of data from human and veterinary medicine, both for antibiotic consumption and for the spread of antibiotic resistance. The first GERMAP report was published in 2008 on the basis of a joint initiative by the Paul Ehrlich Society of Chemotherapy, e.V.PEG), Freiburg infectology (if) and us.
By 2008, there were no reports in Germany and experts and stakeholders could obtain a comprehensive overview of antibiotic consumption and the spread of antimicrobial resistance in the fields of human and veterinary medicine. GERMAP was created to fill that gap. So far, four reports have been published in the series "GERMAP – Antibiotic Resistance and Consumption". Current editors are the Paul Ehrlich Society for Chemotherapy e.V.PEG) and we, that BVL.
The GERMAP Working Group is made up primarily of scientists working in line with the aim of producing a joint report in the field of human or veterinary medicine. They belong to a wide variety of academies, universities, federal ministries and governments. The Task Force demonstrates close interdisciplinary collaboration as they need to implement the Unique Approach to Health ("One World – One Cure – One Health"). German Antibiotic Resistance Strategy (DART 2020) persecuted. GERMAP was considered as an example of "best practice" to strengthen One Health's access to the booklet "Fighting Antimicrobial Resistance" cited in the context of the 2015 G7 meeting in Germany.
The data that GERMAP collects is collected through various monitoring programs and surveys. Consumption data from human medicine come from the Removal Report and the ADKA-if-DGI-Supervision Project of the Federal Association of German Hospital Pharmacists (ADKA), Department of Infectology of the University Hospital Freiburg (if) and the German Infectious Diseases Society (DGI). Data regarding resistance to human medicine in Germany are analyzed PEGResistance studies using SARI (Antibiotic Use and Bacterial Resistance Surveillance in Intensive Care Units), ARS (Antibody Resistance Surveillance) and EARS (European Antimicrobial Resistance Surveillance) and National Reference Centers. Veterinary data mainly come from the collection of antibiotic release amounts and national monitoring of resistance to animal pathogens (GERM-Vet).